The list price for Ozempic is nearly $1,000 for a four-week supply, while Wegovy’s list price is roughly $1,350. While the ...

Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...

Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...

The U.S. Centers for Medicare and Medicaid Services released its list of drugs covered under Medicare Part D selected for the ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Novo Nordisk’s blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

The list price for Ozempic is nearly $1,000 for a four-week supply, while Wegovy’s list price is roughly $1,350. While the negotiations process is expected to yield savings for Medicare ...